Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression

AIMS: This study aims to examine the effectiveness of using sodium glucose transporter-2 inhibitor (SGLT-2i) before hospital admission on Covid-19 outcomes in diabetic patients. METHODS: A literature search was conducted using specific keywords until October 24th, 2022 on 4 databases: Medline, Scopu...

Descripción completa

Detalles Bibliográficos
Autores principales: Permana, Hikmat, Audi Yanto, Theo, Ivan Hariyanto, Timotius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731816/
https://www.ncbi.nlm.nih.gov/pubmed/36502891
http://dx.doi.org/10.1016/j.diabres.2022.110205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731816/
https://www.ncbi.nlm.nih.gov/pubmed/36502891
http://dx.doi.org/10.1016/j.diabres.2022.110205

Ejemplares similares